Patents by Inventor Thomas Lanthorn

Thomas Lanthorn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Memory and learning impairments associated with disruption of Ephrin receptor A6 (EphA6) gene
    Publication number: 20080031871
    Abstract: The present application is a continuation-in-part under 37 C.F.R. 1.53(b) of pending prior international application PCT/US2007/61927 filed on Feb. 9, 2007, which claims priority to provisional application No. 60/774,895 filed on Feb. 17, 2006, now abandoned, the entire disclosures of which are hereby expressly incorporated by reference in their entirety.
    Type: Application
    Filed: May 15, 2007
    Publication date: February 7, 2008
    Inventors: Margaret Allen, Joel Edwards, Thomas Lanthorn, Katerina Savelieva
  • Methods and compositions for improving cognition
    Publication number: 20060258691
    Abstract: This invention encompasses methods of improving cognitive performance and of treating, preventing and managing various diseases and disorders, such as Alzheimer's disease, autism, cognitive disorders, dementia, learning disorders, and short- and long-term memory loss.
    Type: Application
    Filed: May 12, 2006
    Publication date: November 16, 2006
    Inventors: Joseph Barbosa, Li Dong, Cynthia Fink, Thomas Lanthorn, Jiancheng Wang, G. Zipp
  • Positive modulators of nicotinic receptors
    Patent number: 6861443
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Grant
    Filed: March 20, 2001
    Date of Patent: March 1, 2005
    Assignee: Astra AB
    Inventors: David Gurley, Thomas Lanthorn
  • Positive modulators of nicotinic receptor agonists
    Patent number: 6750242
    Abstract: Compounds of Formula I wherein R1, R2, R3 and R4 are as defined in the specification, enantiomers thereof, pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical compositions containing them and their use in therapy, especially for treatment of conditions associated with reductions in nicotinic transmission. The compounds of the invention enhance the efficacy of agonists at nicotinic receptors.
    Type: Grant
    Filed: September 23, 2002
    Date of Patent: June 15, 2004
    Assignee: AstraZeneca AB
    Inventors: David Gurley, Thomas Lanthorn, John Macor, James Rosamond
  • Use
    Publication number: 20010041732
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Application
    Filed: March 20, 2001
    Publication date: November 15, 2001
    Inventors: David Gurley, Thomas Lanthorn
  • Use
    Patent number: 6277870
    Abstract: The present invention relates to pharmaceutical compositions comprising a positive modulator of a nicotinic receptor agonist, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist.
    Type: Grant
    Filed: May 4, 1998
    Date of Patent: August 21, 2001
    Assignee: Astra AB
    Inventors: David Gurley, Thomas Lanthorn